FR1601721A - Stabilisation of ascorbic acid - Google Patents

Stabilisation of ascorbic acid

Info

Publication number
FR1601721A
FR1601721A FR1601721DA FR1601721A FR 1601721 A FR1601721 A FR 1601721A FR 1601721D A FR1601721D A FR 1601721DA FR 1601721 A FR1601721 A FR 1601721A
Authority
FR
France
Prior art keywords
ascorbic acid
fat
stabilisation
vit
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1601721A publication Critical patent/FR1601721A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Fodder In General (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1601721D 1962-08-16 1963-08-01 Stabilisation of ascorbic acid Expired FR1601721A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM53915A DE1207374B (de) 1962-08-16 1962-08-16 Verfahren zur Erhoehung der Bestaendigkeit von fester 1-Ascorbinsaeure

Publications (1)

Publication Number Publication Date
FR1601721A true FR1601721A (en) 1970-09-14

Family

ID=7307859

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1601721D Expired FR1601721A (en) 1962-08-16 1963-08-01 Stabilisation of ascorbic acid

Country Status (3)

Country Link
DE (1) DE1207374B (fr)
FR (1) FR1601721A (fr)
NL (1) NL296020A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3042648A1 (fr) 2014-12-23 2016-07-13 Hermes Arzneimittel GmbH Granules directs a agent actif retarde

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES355628A1 (es) * 1967-06-30 1969-12-16 Hoffmann La Roche Procedimiento para la estabilizacion de acido ascorcibo y sus derivados.
CH527570A (fr) * 1971-02-10 1972-09-15 Nestle Sa Procédé de fabrication de granules d'un produit acide
FR2526273A1 (fr) * 1982-05-04 1983-11-10 Guibert Jacques Methodes permettant l'enrichissement de produits fragiles sans deterioration de leurs qualites pharmacologiques au sein d'aliments dietetiques
IT1312058B1 (it) * 1999-04-09 2002-04-04 Pharmaplus S R L Metodo per la microincapsulazione di medicamenti.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE533913A (fr) *
DE1051848B (de) * 1956-10-20 1959-03-05 Merck Ag E Verfahren zur Erhoehung der Bestaendigkeit von fester Ascorbinsaeure
US2980702A (en) * 1958-11-15 1961-04-18 Merck Ag E Heat resistant derivatives of l-ascorbic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3042648A1 (fr) 2014-12-23 2016-07-13 Hermes Arzneimittel GmbH Granules directs a agent actif retarde

Also Published As

Publication number Publication date
NL296020A (fr)
DE1207374B (de) 1965-12-23

Similar Documents

Publication Publication Date Title
AT249269B (de) Verfahren zur Herstellung von Arzneimitteln in fester Form mit gesteuerter Wirkstoffreigabe
FR1601721A (en) Stabilisation of ascorbic acid
BE588774A (fr) Procédé de préparation de quinacridones linéaires sous forme pigmentaire par cyclisation d'acides 2,5-diarylamino téréphtaliques.
GB934087A (en) Method of manufacturing water soluble polyvinyl alcohol derivatives
JPS5247097A (en) Process for preparing polyesters suitable for films with high turbidit y
Romashev et al. Role of the Magnetic State of the Gamma Phase in Fe-Cr-Ni Alloys in the Gamma to Alpha Structural Transformation Under the Influence of a Magnetic Field
DK105066C (da) Fremgangsmåde til fremstilling af 3-(2-pyrrolidinyl)-indoler eller syreadditionssalte deraf.
JPS5237057A (en) Lens
JPS5238934A (en) Cine camera able to record simultaneously
ANDRADE Apparatus for the measurement of the progress of metal shear strain with time, allowing photomicrographs to be taken simultaneously
GB1101733A (en) A process for the preparation of d-glucosaccharo-1,4-lactone
JPS5246017A (en) Process for preparation of farnesyl acetates
VENINI Relativistic behavior of an observer in uniformly accelerated translational motion relative to an inertial observer(Relativistic behavior of uniformly accelerated translational observer motion relative to inertial observer from space-time transformation)
IE38557B1 (en) Process for the preparation of 1-nitroanthraquinone which is practically free of 1-5-dinitroanthraquinone
BELICH Role of ozone in the formation of the general stratospheric circulation(Stratospheric circulation, investigating ozone heating role in temperature field formation by numerical experiment)
DK132224B (da) Analogifremgangsmåde til fremstilling af diaza-1,4-bicyclo(4,4,0)-benzo-(1,2,h)-decan-derivater eller syreadditionssalte deraf.
GB970500A (en) Improvements in or relating to the production of coloured aluminium
DK105025C (da) Fremgangsmåde til fremstilling af umættede 9,10-dihydro-10,10,-dimethylanthracenderivater eller syreadditionssalte deraf.
FR2031806A5 (en) 17beta-spiro-oxiranes of the oestrane series
GAREIS Kinetics of reaction of chlorine dioxide with nitrogen dioxide in solution phase
SCHILLMANN Segragation of impurities in indium arsenide, determining distribution coefficients on samples prepared by the two-temperature process
GOLDBERG Solution of equations of motion for the general theory of relativity using the einstein-infeld- hoffmann approximation as compared to other approximation methods
Poplavnoi et al. Influence of Anion Displacements on the Energy Band Structure of Crystals With the Chalcopyrite Lattice
Shimizu et al. Two Cases of Pelvic Sarkoma
NL6901216A (en) 17beta-spiro-oxiranes of the oestrane series